Vericel Announces FDA Approval of NexoBrid for the Treatment of Pediatric Patients with Severe Thermal Burns

Vericel announces FDA approval of NexoBrid for pediatric severe thermal burns, offering a non-surgical eschar removal solution.


© Copyright 2024. All Rights Reserved by MedPath